Immediate Impact
4 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Lung cancer in patients who have never smoked — an emerging disease
2024 Standout
Works of Alejo Lingua being referenced
First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients (pts) with metastatic non–small cell lung cancer (NSCLC): 3-year update from CheckMate 9LA.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alejo Lingua | 38 | 38 | 15 | 21 | 4 | 55 | |
| Rebecca Kalikawe | 21 | 36 | 14 | 26 | 5 | 60 | |
| Tasha Lea | 26 | 18 | 15 | 6 | 2 | 47 | |
| Mohammed Quraishi | 15 | 12 | 14 | 20 | 3 | 58 | |
| Anant Desai | 51 | 19 | 13 | 23 | 4 | 71 | |
| Ilona Dahmen | 12 | 21 | 42 | 17 | 3 | 84 | |
| V.S. Sakalo | 70 | 61 | 20 | 9 | 4 | 80 | |
| Sharmila Sothi | 15 | 38 | 6 | 14 | 3 | 57 | |
| Daniele Lomiento | 33 | 17 | 6 | 27 | 5 | 57 | |
| Vinicius S Chagas | 16 | 14 | 29 | 11 | 4 | 48 | |
| George Alexiadis | 10 | 28 | 16 | 23 | 5 | 69 |
All Works
Loading papers...